|
Market Closed -
OTC Markets
15:51:25 2026-09-09 EDT
|
5-day change | 1st Jan Change | ||
| 0.0190 USD | +5.44% |
|
-0.26% | -69.06% |
| 08-13 | CV Sciences, Inc., Q2 2026 Earnings Call, Aug 13, 2026 | |
| 08-13 | CV Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Company Valuation: CV Sciences, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 47.1 | 13.04 | 4.945 | 5.465 | 6.228 | 11.31 |
| Change | - | -72.32% | -62.06% | 10.51% | 13.96% | 81.66% |
| Enterprise Value (EV) 1 | 50.85 | 12.58 | 5.862 | 4.59 | 6.553 | 13.03 |
| Change | - | -75.25% | -53.41% | -21.7% | 42.76% | 98.86% |
| P/E | -2.11x | -0.81x | -0.44x | 1.77x | -2.48x | -11.8x |
| PBR | 4.22x | 3.7x | -6.34x | 1.97x | 3.47x | 7.71x |
| PEG | - | 0x | 0x | -0x | 0x | 0.2x |
| Capitalization / Revenue | 1.93x | 0.65x | 0.31x | 0.34x | 0.4x | 0.82x |
| EV / Revenue | 2.08x | 0.63x | 0.36x | 0.29x | 0.42x | 0.95x |
| EV / EBITDA | -2.34x | -1.03x | -1.27x | 1.19x | -7.8x | -46.9x |
| EV / EBIT | -2.25x | -0.94x | -1.04x | 1.27x | -5.58x | -27.7x |
| EV / FCF | -50.9x | -6.34x | -32.5x | 10.4x | 13.4x | -62.1x |
| FCF Yield | -1.97% | -15.8% | -3.07% | 9.57% | 7.46% | -1.61% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.223 | -0.1443 | -0.0728 | 0.02 | -0.0136 | -0.005199 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 24.43 | 20.05 | 16.2 | 16 | 15.7 | 13.79 |
| EBITDA 1 | -21.72 | -12.26 | -4.621 | 3.846 | -0.84 | -0.278 |
| EBIT 1 | -22.59 | -13.41 | -5.613 | 3.611 | -1.174 | -0.47 |
| Net income 1 | -22.28 | -15.55 | -9.134 | 3.102 | -2.394 | -0.958 |
| Net Debt 1 | 3.75 | -0.453 | 0.917 | -0.875 | 0.325 | 1.718 |
| Reference price 2 | 0.4700 | 0.1166 | 0.0324 | 0.0354 | 0.0338 | 0.0614 |
| Nbr of stocks (in thousands) | 100,203 | 111,796 | 152,635 | 154,605 | 184,264 | 184,264 |
| Announcement Date | 3/19/21 | 4/4/22 | 3/30/23 | 3/29/24 | 3/27/25 | 3/26/26 |
1USD in Million2USD
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 4.29M | |
| 32x | 11.63x | 23.59x | 0.62% | 1,002B | |
| 28.37x | 6.53x | 17.91x | 2.01% | 644B | |
| 32.13x | 7.46x | 15.49x | 2.73% | 443B | |
| 18.9x | 4.61x | 11.42x | 2.88% | 343B | |
| 19.46x | 5.11x | 12.69x | 3.2% | 262B | |
| 20.29x | 4.17x | 11.93x | 2.12% | 245B | |
| 24.75x | 6.5x | 11.57x | 2.58% | 212B | |
| 12.86x | 4.67x | 9.75x | 3.91% | 199B | |
| -44.5x | 6.43x | 25.11x | 2.26% | 181B | |
| Average | 16.03x | 6.35x | 15.50x | 2.48% | 352.97B | |
| Weighted average by Cap. | 22.91x | 7.53x | 17.31x | 2.04% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CVSI Stock
- Valuation CV Sciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
